Oxymorphone Hydrochloride Articles
Watson acquires Uteron Pharma; confirms Opana patent challenge
24 January 2013
Endo buys US generics firm Qualitest for $1.2 billion
29 September 2010
Opana growth drives Endo's profit up 15%
16 March 2009
Endo/Penwest settle Opana litigation
2 March 2009
FDA clears three new Opana ER strengths
10 March 2008
Showing 1-6 of 6 articles
- 1
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Is the diabetes market facing a blockbuster-free future?
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
